Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 26

Sort by

Sort Order Select

Journal Articles

Response-Adaptive Phase II Study of Daratumumab Combined with Carfilzomib, Lenalidomide and Dexamethasone in Newly Diagnosed Multiple Myeloma

Manisha Bhutani, MD, Monika House, RN, BA, Jiaxian He, MS, Shebli Atrash, David M Foureau, PhD, Barry Paul, MDMS, Reed Friend, MD, James T Symanowski, PhD, Sarah Norek, BSN, RN, Xhevahire Begic, MSPH, Donna Acampora, BSN, RN, Katherine K Farmer, BA, Carrie Ann Syfert, BSN, RN, Mauricio Pineda-Roman, MD, Peter Voorhees, MD, Saad Z. Usmani, MDMBBS,MBA

Blood (2020) 136 (Supplement 1): 38–39.

https://doi.org/10.1182/blood-2020-138485

Published: 2020

Journal Articles

Phase II Trial of In Vivo Purging with Daratumumab in Newly Diagnosed Multiple Myeloma

Shebli Atrash, MD, Myra Robinson, MSPH, Barry Paul, MDMS, Sarah Norek, BSN, RN, David M. Foureau, PhD, Carrie Ann Syfert, BSN, RN, Ami P Ndiaye, NP, James T Symanowski, PhD, Jordan Robinson, Manisha Bhutani, MD, Peter M. Voorhees, MD, Saad Z. Usmani, MDMBBS,MBA

Blood (2020) 136 (Supplement 1): 19–20.

https://doi.org/10.1182/blood-2020-141562

Published: 2020

Journal Articles

Minorities Do Not Have Worse Outcomes for Diffuse Large B Cell Lymphoma (DLBCL) If Optimally Managed

Bei Hu, MD, Tommy Chen, Danielle Boselli, MS, Rupali Bose, MS, MBA, James T. Symanowski, PhD, Derek Raghavan, MDPhDFACP,FRACP, Amy Soni, MD, Steven I Park, MD, Belinda R Avalos, MD, Edward A Copelan, Ryan Jacobs, MD, Nilanjan Ghosh, MD PhD

Blood (2019) 134 (Supplement_1): 425.

https://doi.org/10.1182/blood-2019-123998

Published: 2019

Journal Articles

Phase I/II Study of Carfilzomib, Ruxolitinib and Low-Dose Dexamethasone for Carfilzomib-Refractory Multiple Myeloma (CarJak)

Shebli Atrash, MD, Myra Robinson, MS, Manisha Bhutani, MD, Jeffrey A. Zonder, Reed Friend, MD, Barry Paul, MD, Daniel Auclair, Jordan Robinsons, Ami P Ndiaye, NP, Kelly Bumgarner, Sarah Norek, James T. Symanowski, PhD, Peter M. Voorhees, MD, Saad Z. Usmani, MDMBBS

Blood (2019) 134 (Supplement_1): 5570.

https://doi.org/10.1182/blood-2019-130290

Published: 2019

Journal Articles

Use of Buprenorphine/Naloxone in Ameliorating Acute Care Utilization and Chronic Opioid Use in Adults with Sickle Cell Disease

Ifeyinwa (ify) Osunkwo, MD MPH, Padmaja Veeramreddy, MD, Justin Arnall, PharmD, CPP, BCOP, Rachel Crawford, PharmD, BCPS, James T Symanowski, PhD, Rasaq Olaosebikan, MD MSc, Srinivasa Reddy Sanikommu, MD, Stephanie Newby, MD, Stephen Wyatt, DO, Jamie Sebaaly, Katherine Rector

Blood (2019) 134 (Supplement_1): 790.

https://doi.org/10.1182/blood-2019-126589

Published: 2019

Journal Articles

Patient Reported Financial Toxicity in Myeloproliferative Neoplasms

Thomas G. Knight, MD, Myra Robinson, MS, Jing Ai, MD PhD, Brittany K Ragon, MD, Rhonda Davis, RN, BSN, Cindy Shiflett, LPN, Erica Ruston, RN, BSN, Hailey Glover, RN, BSN, Jigar Trivedi, MSc, PharmD, Belinda R Avalos, MD, Jonathan M. Gerber, MD, James T Symanowski, PhD, Edward A Copelan, Michael R. Grunwald, MD

Blood (2019) 134 (Supplement_1): 2099.

https://doi.org/10.1182/blood-2019-128858

Published: 2019

Journal Articles

Survival and Time to Response with Frontline Hypomethylating Agents in AML

Jing Ai, MD, Danielle Boselli, MS, Lauren M. Bohannon, Thomas G. Knight, MD, Brittany Ragon, MD, Belinda Rene Avalos, MD, Edward A. Copelan, MD, James T Symanowski, PhD, Jonathan M. Gerber, MD, Michael R. Grunwald, MD

Blood (2018) 132 (Supplement 1): 4035.

https://doi.org/10.1182/blood-2018-99-119463

Published: 2018

Journal Articles

Higher Incidence of Hemorrhagic Cystitis after Haploidentical Compared to Matched Sibling Donor Transplantation

Srinivasa Reddy Sanikommu, MD, Olivia Copelan, BA, Jiaxian He, MS, Candace M. Butler, MSPH, Michael R. Grunwald, MD, Nilanjan Ghosh, MD PhD, Jing Ai, MD, Thomas G. Knight, MD, Brittany Ragon, MD, Ryan Jacobs, MD, Bei Hu, Saad Z. Usmani, MD, James T Symanowski, PhD, Zainab Shahid, MD

Blood (2018) 132 (Supplement 1): 3380.

https://doi.org/10.1182/blood-2018-99-119612

Published: 2018

Journal Articles

Evaluation of Intravenous Diphenhydramine Use in Patients with Sickle Cell Vaso-Occlusive Crisis

Ifeyinwa Osunkwo, MD MPH, Shelby Merchant, PharmD, Rachel Crawford, PharmD, BCPS, Katherine Rector, PharmD, BCPS, Justin Arnall, PharmD, CPP, BCOP, James T Symanowski, PhD, Padmaja Veeramreddy, MD

Blood (2018) 132 (Supplement 1): 3575.

https://doi.org/10.1182/blood-2018-99-116848

Published: 2018

Journal Articles

Patient Reported Financial Toxicity in Acute Leukemia

Thomas G. Knight, MD, Myra Robinson, MS, Michael R. Grunwald, MD, Lauren M. Bohannon, Erin Blackwell, RN, BSN, OCN, Jing Ai, MD, Brittany Ragon, MD, Rhonda Davis, BSN, RN, Cindy Shiflett, LPN, Erica Ruston, RN, BSN, Jigar Trivedi, MSc, PharmD, Justin Arnall, PharmD, CPP, BCOP, Belinda Rene Avalos, MD, James T Symanowski, PhD, Edward A. Copelan, MD, Jonathan M. Gerber, MD

Blood (2018) 132 (Supplement 1): 4796.

https://doi.org/10.1182/blood-2018-99-119163

Published: 2018

Journal Articles

De-Escalation of Antimicrobials in Adult Hematopoietic Cell Transplantation Recipients with Febrile Neutropenia of Unknown Origin

Megan M. Petteys, PharmD, Ekaterina Kachur, PharmD, Kelly E. Pillinger, PharmD, Jiaxian He, MS, James T. Symanowski, PhD, Candace M. Butler, MSPH, Lynn S. Sanders, MSN, RN, OCN, Nilanjan Ghosh, MD PhD, Michael R. Grunwald, MD, Belinda Rene Avalos, MD, Saad Z. Usmani, MD, Edward A. Copelan, MD, Zainab Shahid, MD

Blood (2018) 132 (Supplement 1): 2079.

https://doi.org/10.1182/blood-2018-99-117148

Published: 2018

Journal Articles

Busulfan Pharmacogenetics and Drug Exposure in Cancer Patients Undergoing Hematopoietic Stem Cell Transplantation

Jai N Patel, PharmD, Issam Hamadeh, BS, Qing Zhang, PhD, Taylor Brown, BS, MS, Nury M Steuerwald, PhD, Alicia Hamilton, Lawrence J Druhan, PhD, Jiaxian He, MS, James T Symanowski, PhD, Mohammed J Hussain, MD, Jigar Trivedi, MSc, PharmD, Michael Richard Grunwald, MD, Nilanjan Ghosh, MD PhD, Belinda Rene Avalos, MD, Edward A Copelan, MD

Blood (2017) 130 (Supplement 1): 3215.

https://doi.org/10.1182/blood.V130.Suppl_1.3215.3215

Published: 2017

Journal Articles

AcDVP16 Induction Therapy for Acute Myeloid Leukemia

Michael Richard Grunwald, MD, Amy M. Ellenburg, PharmD, Michael Keith Allister Zimmerman, MS, Jing Ai, MD PhD, Thomas G. Knight, MD, Lauren M. Bohannon, Danielle Boselli, MS, Jigar Trivedi, MSc, PharmD, Margaret A. Croom, PharmD, William E. Anderson, JD, MS, James T Symanowski, PhD, Edward A Copelan, MD, Dragos Plesca, PharmD, Jonathan M. Gerber, MD

Blood (2017) 130 (Supplement 1): 3902.

https://doi.org/10.1182/blood.V130.Suppl_1.3902.3902

Published: 2017

Journal Articles

Frontline Azacitidine As a Bridge to Allogeneic Transplantation in Acute Myeloid Leukemia

Michael Richard Grunwald, MD, Michael Keith Allister Zimmerman, MS, Danielle Boselli, MS, Lauren M. Bohannon, Myra M Robinson, MSPH, Daniel T. Peters, Jing Ai, MD PhD, Thomas G. Knight, MD, Jigar Trivedi, MSc, PharmD, Dragos Plesca, PharmD, James T Symanowski, PhD, Edward A Copelan, MD, Jonathan M. Gerber, MD

Blood (2017) 130 (Supplement 1): 3864.

https://doi.org/10.1182/blood.V130.Suppl_1.3864.3864

Published: 2017

Journal Articles

A Value-Based Approach to Optimizing Peripheral Blood Progenitor Cell (PBPC) Mobilization and Collection for Autologus Hematopoietc Cell Transplantation (AHCT)

Srinivasa Reddy Sanikommu, MD, Emily S Reese, PhD MPH, Carlos Lee, Jiaxian He, MS, Daisuke Goto, PhD, Omotayo O. Fasan, MBBS, Kimberly Ward, Saad Z Usmani, MD, Nilanjan Ghosh, MD PhD, Manisha Bhutani, MD, Ryan Jacobs, MD, Peter M. Voorhees, MD, Sarah Lestrange, MS, Jigar Trivedi, MSc, PharmD, Carol Farhangfar, PhD, James T Symanowski, PhD, Edward A Copelan, MD, Belinda Rene Avalos, MD

Blood (2017) 130 (Supplement 1): 4717.

https://doi.org/10.1182/blood.V130.Suppl_1.4717.4717

Published: 2017

Journal Articles

Comparison of Biologically Assigned HLA-Identical Versus Haploidentical Related Donor Hematopoietic Stem Cell Transplantation

Blood (2017) 130 (Supplement 1): 4605.

https://doi.org/10.1182/blood.V130.Suppl_1.4605.4605

Published: 2017

Journal Articles

Peripheral Cellular Immunome Reveals Heterogeneity Spanning Myeloma Spectrum Diseases

Manisha Bhutani, MD, David M Foureau, PhD, Qing Zhang, PhD, Myra M Robinson, MSPH, Adina Wynn, Nury M Steuerwald, PhD, Lawrence J Druhan, PhD, Fei Guo, PhD, Katherine Rigby, Mitchell Turner, Reed Friend, MD, Shebli Atrash, Ami Ndiaye, Chelsea Sprouse, James T Symanowski, PhD, Belinda Rene Avalos, MD, Edward A Copelan, MD, Peter M. Voorhees, MD, Saad Z Usmani, MD

Blood (2017) 130 (Supplement 1): 3054.

https://doi.org/10.1182/blood.V130.Suppl_1.3054.3054

Published: 2017

Journal Articles

Effect of Immunomodulatory Drugs (IMiDs) on Immune Effectors after Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma

David M Foureau, PhD, Manisha Bhutani, MD, Qing Zhang, PhD, Myra M Robinson, MSPH, Adina Wynn, Nury M Steuerwald, PhD, Lawrence J Druhan, PhD, Fei Guo, PhD, Katherine Rigby, Mitchell Turner, Reed Friend, MD, Shebli Atrash, Chelsea Sprouse, Ami Ndiaye, James T Symanowski, PhD, Belinda Rene Avalos, MD, Edward A Copelan, MD, Peter M. Voorhees, MD, Saad Z Usmani, MD

Blood (2017) 130 (Supplement 1): 1817.

https://doi.org/10.1182/blood.V130.Suppl_1.1817.1817

Published: 2017

Journal Articles

Validation of Dynamic Biomarker-Based Risk Progression Model for Smoldering Multiple Myeloma

Shebli Atrash, Myra M Robinson, MSPH, Amanda Aneralla, Taylor Brown, BS, MS, Reed Friend, MD, Chelsea Sprouse, Ami Ndiaye, Qing Zhang, PhD, Edward H Lipford, MD, Jared G Block, MD, Elton T Smith, MD, James T Symanowski, PhD, Belinda Rene Avalos, MD, Edward A Copelan, MD, Peter M. Voorhees, MD, Saad Z Usmani, MD, Manisha Bhutani, MD

Blood (2017) 130 (Supplement 1): 1779.

https://doi.org/10.1182/blood.V130.Suppl_1.1779.1779

Published: 2017

Journal Articles

Outcomes of Patients with Newly Diagnosed Aggressive B Cell Lymphoma Presenting with Hepatic and/ or Renal Dysfunction

Nilanjan Ghosh, MD PhD, Jigar Trivedi, MSc, PharmD, Srinivasa Reddy Sanikommu, MD, Myra M Robinson, MSPH, Ryan Jacobs, MD, Steven I Park, MD, Danyu Sun, MD PhD, James T Symanowski, PhD, Taylor Brown, BS, MS, Belinda Rene Avalos, MD, Edward A Copelan, MD

Blood (2017) 130 (Supplement 1): 5225.

https://doi.org/10.1182/blood.V130.Suppl_1.5225.5225

Published: 2017

NARROW

Response-Adaptive Phase II Study of Daratumumab Combined with Carfilzomib, Lenalidomide and Dexamethasone in Newly Diagnosed Multiple Myeloma

Phase II Trial of In Vivo Purging with Daratumumab in Newly Diagnosed Multiple Myeloma

Minorities Do Not Have Worse Outcomes for Diffuse Large B Cell Lymphoma (DLBCL) If Optimally Managed

Phase I/II Study of Carfilzomib, Ruxolitinib and Low-Dose Dexamethasone for Carfilzomib-Refractory Multiple Myeloma (CarJak)

Use of Buprenorphine/Naloxone in Ameliorating Acute Care Utilization and Chronic Opioid Use in Adults with Sickle Cell Disease

Patient Reported Financial Toxicity in Myeloproliferative Neoplasms

Survival and Time to Response with Frontline Hypomethylating Agents in AML

Higher Incidence of Hemorrhagic Cystitis after Haploidentical Compared to Matched Sibling Donor Transplantation

Evaluation of Intravenous Diphenhydramine Use in Patients with Sickle Cell Vaso-Occlusive Crisis

Patient Reported Financial Toxicity in Acute Leukemia

De-Escalation of Antimicrobials in Adult Hematopoietic Cell Transplantation Recipients with Febrile Neutropenia of Unknown Origin

Busulfan Pharmacogenetics and Drug Exposure in Cancer Patients Undergoing Hematopoietic Stem Cell Transplantation

AcDVP16 Induction Therapy for Acute Myeloid Leukemia

Frontline Azacitidine As a Bridge to Allogeneic Transplantation in Acute Myeloid Leukemia

A Value-Based Approach to Optimizing Peripheral Blood Progenitor Cell (PBPC) Mobilization and Collection for Autologus Hematopoietc Cell Transplantation (AHCT)

Comparison of Biologically Assigned HLA-Identical Versus Haploidentical Related Donor Hematopoietic Stem Cell Transplantation

Peripheral Cellular Immunome Reveals Heterogeneity Spanning Myeloma Spectrum Diseases

Effect of Immunomodulatory Drugs (IMiDs) on Immune Effectors after Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma

Validation of Dynamic Biomarker-Based Risk Progression Model for Smoldering Multiple Myeloma

Outcomes of Patients with Newly Diagnosed Aggressive B Cell Lymphoma Presenting with Hepatic and/ or Renal Dysfunction

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only